12:51 PM
 | 
Jan 04, 2019
 |  BC Extra  |  Company News

Genentech, Adaptive Biotechnologies to develop cancer T cell therapies

Adaptive Biotechnologies Corp. (Seattle, Wash.) and Genentech Inc. partnered to develop personalized and off-the-shelf T cell therapies for a broad range of cancers using Adaptive's TruTCR discovery and immune profiling platform. TruTCR...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >